Meet Physicians and Scientists

Tucker Roussin is a four-year-old healthy boy. When his mother, Katie, was 20 weeks pregnant, he was diagnosed with a pericardial teratoma, an extremely rare tumor that grows on the lining surrounding the heart. The tumor was almost as large as his tiny heart, and it was growing quickly. Clinicians at the Center for Fetal Diagnosis and Treatment at Children’s Hospital of Philadelphia (CHOP) recommended an open fetal surgery to remove the tumor.

Samuel L. Katz, MD, described himself as merely a “young, enthusiastic, and naïve pediatrician” who “came along at the right time, in the right laboratory, with the right colleagues.” This is a remarkably humble reframing of the accomplishments of the pioneering virologist, pediatrician, and chairman emeritus and Wilburt C. Davison Professor Emeritus of Pediatrics at Duke University School of Medicine.

The push to develop treatments for Alzheimer’s disease has been a promising and disappointing endeavor over the past two decades, yielding a greater understanding of the disease yet still failing to generate successful new drugs.

“One day, patients will have access to regenerative medicine treatments that will circumvent the complications of organ donation,” says Sharlini Sankaran, PhD, executive director of Duke’s Regeneration Next Initiative. “We will be able to use our bodies’ own innate repair mechanisms to eliminate the wait time, cost, and limited supply of organ transplantation. Instead of transplanting organs, we will know how to repair our own.”